Navigation Links
Progesterone Found To Increase Ovarian Cancer Risk

A new genetic discovery could help give insight into a very deadly disease. Latest research shows two variations in the gene // that codes for the progesterone receptor increase a woman’s risk of ovarian cancer.

The PGR had previously been linked to a higher ovarian cancer risk as well as a lower breast cancer risk in women who carry it. Researchers used biological samples from an ongoing study and examined the variety of gene variations found in the PGR gene to see if there was an association with the risk for ovarian cancer in women.

While scientists say the PGR likely does play a role in the risk of ovarian cancer, they discovered something even more interesting. They found the greatest influence on ovarian cancer risk came from two variations of the gene. These two variations raised a woman’s ovarian cancer risk by nearly four-fold.

In conclusion researchers say they know progesterone appears to protect women from ovarian cancer, while increasing their risk of breast cancer and it was observed that changes in the progesterone receptor, which is what the progesterone hormone does, might decrease the receptor’s efficiency, reducing the influence on the body’s cell. This can lead to ovarian cancer. However, they say that more such studies should be done in the future to confirm this theor.
'"/>




Page: 1

Related medicine news :

1. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
2. Fluoride Found Effective in Osteoporosis
3. Implantable Contact Lens Found Safe and Effective
4. Cancer hazard Found With Animal-Based Nutrients
5. Processed Meat, Diabetes connection Found
6. Night Time Aspirin Regimen Found to Reduce Blood Pressure
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
9. Preventive Therapies Found to be More Effective in Managing Migraines
10. Common Cold Found to Fight Cancer
11. Circumcision Found To Prevent HIV Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... Chicago, Illinois (PRWEB) , ... April 24, 2017 , ... ... home. What happened next changed her life forever. , In “Healing Tears,” James depicts ... “At the advice of my attorney, I began journaling conversations and situations throughout my ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, ... supplements, announced its popular products are now available for purchase on StackedNutrition.com, a ... the use of premium natural ingredients in making all of its products. These ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South ... are now available for purchase on RevNutrition.com, a popular website specializing in sales of ... and popularized in ancient India and Siam. It spread across Asia and Africa quickly, ...
(Date:4/24/2017)... HOUSTON, TEXAS (PRWEB) , ... April 24, 2017 ... ... service (SaaS) based healthcare compliance and credentialing solutions, today announced that Kyle Allain ... Allain leads symplr’s Cactus Provider Management sales and operations, including provider, payor and ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... tumors are expected to be diagnosed globally; approximately 25,000 of them will be ... anticipating greater use of this type of healthcare model in the diagnosis and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
Breaking Medicine Technology: